Lumida
/OMCL
⌘K
Omnicell Inc

Omnicell Inc

OMCL
$32.79USD+1.67%+0.54 today

MARKET CAP

1.5B

P/E (TTM)

74.5x

FWD P/E

DAY RANGE

$32 – $33

52W RANGE

$29
$55

AI Summary

Stalk
Sell NowMedium

OMCL remains in a sustained downtrend, forming sequential lower highs and lower lows under a declining EMA/SMA stack. Medium-term bias is bearish, and short-term timing is favorable as price is rejecting rallies into the 9-day and 20-day EMA resistance zone. Execution favors selling now into that EMA region. Key risks include a potential oversold bounce and any sustained break above the EMA resistance that would invalidate the bearish structure.

  • Q1 2026 revenue $310M (+15% YoY); non-GAAP EBITDA $45M
  • ARR projected at $680–700M by end-2026
  • Non-GAAP gross margins fell to 50%, profitability score negative
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$1.1B$1.3B$1.1B$1.1B$1.2B
YoY %+26.9%+14.5%-11.5%-3.0%+6.5%
P / Sales7.6x1.8x1.5x1.9x1.8x
EV / Sales8.2x2.4x2.0x2.3x2.2x
Gross Profit, Adj.$554.7M$589.0M$496.8M$471.0M$503.4M
YoY %+34.2%+6.2%-15.6%-5.2%+6.9%
Margin %49.0%45.4%43.3%42.3%42.5%
EV / Gross Profit16.8x5.3x4.5x5.5x5.3x
EBITDA, Adj.$174.4M$84.6M$52.5M$82.6M$84.0M
YoY %+80.6%-51.5%-38.0%+57.4%+1.7%
Margin %15.4%6.5%4.6%7.4%7.1%
EV / EBITDA53.3x36.8x43.0x31.1x31.5x
EBIT$89.5M$-2.3M$-34.9M$337,000$5.2M
YoY %+151.9%-102.6%-1401.0%+101.0%+1431.2%
Margin %7.9%-0.2%-3.0%0.0%0.4%
EV / EBIT103.9x-1341.1x-64.8x7619.3x512.9x
Net Income$77.8M$5.6M$-20.4M$12.5M$2.1M
YoY %+141.8%-92.7%-460.7%+161.5%-83.6%
Net Margin6.9%0.4%-1.8%1.1%0.2%
EPS (GAAP)$1.62$0.12-$0.45$0.27$0.04
YoY %+118.9%-92.6%-475.0%+160.0%-85.2%